C
ISSUER//CIK 0001817944
Clarus Therapeutics Holdings, Inc.
Exchange
—
Entity type
operating
Fiscal year end
Dec 31
Headquarters
DE
Recent Filings
- 8-K211.9 KBClarus Therapeutics Holdings, Inc.Mar 1, 7:26 AM ET·0001213900-23-015846
- 8-K7.0 MBClarus Therapeutics Holdings, Inc.Feb 22, 4:18 PM ET·0001213900-23-013683
- SC 13G/A90.8 KBClarus Therapeutics Holdings, Inc.Feb 14, 12:29 PM ET·0001172661-23-001071
- 8-K6.9 MBClarus Therapeutics Holdings, Inc.Jan 24, 4:01 PM ET·0001213900-23-004819
- 8-K6.9 MBClarus Therapeutics Holdings, Inc.Dec 22, 4:22 PM ET·0001213900-22-082213
- 8-K11.1 MBClarus Therapeutics Holdings, Inc.Nov 23, 6:09 AM ET·0001213900-22-074705
- 8-K732.9 KBClarus Therapeutics Holdings, Inc.Oct 31, 4:15 PM ET·0001213900-22-067678
- 8-K7.1 MBClarus Therapeutics Holdings, Inc.Oct 24, 4:16 PM ET·0001213900-22-065838
- 8-K220.8 KBClarus Therapeutics Holdings, Inc.Oct 18, 4:10 PM ET·0001213900-22-064699
- 8-K256.1 KBClarus Therapeutics Holdings, Inc.Sep 15, 5:02 PM ET·0001213900-22-056275
Insiders
10- Amory John KennethDirector
- Blue Water Sponsor LLC10% Owner
- Bourne Steven A.Chief Administrative Officer
- Bracebridge Capital, LLC10% Owner
- CBC SPVI Ltd10% Owner
- Cermak ElizabethDirector
- Dudley Robert E.Director, Chief Executive Officer
- FFI FUND LTD10% Owner
- Garfield JonChief Financial Officer
- Hernandez JosephDirector
Tickers
No tickers on record
Addresses
business
355 S. GRAND AVENUE, SUITE 1450
LOS ANGELES, CA, 90071
mailing
355 S. GRAND AVENUE, SUITE 1450
LOS ANGELES, CA, 90071
Former Names
- Blue Water Acquisition Corp.2021-09-09